Zurcher Kantonalbank (Zurich Cantonalbank) Puma Biotechnology, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$2.13 - $3.24 $2 - $3	-1 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$2.85 - $6.58 $5,309 - $12,258	-1,863 Reduced 99.95%	1 $0
Q2 2021 Jul 30, 2021	SELL	$8.98 - $11.6 $27,299 - $35,264	-3,040 Reduced 61.99%	1,864 $17,000
Q2 2020 Jul 28, 2020	BUY	$7.01 - $13.24 $21,759 - $41,096	3,104 Added 172.44%	4,904 $51,000
Q1 2020 May 06, 2020	SELL	$6.28 - $14.57 $5,645 - $13,098	-899 Reduced 33.31%	1,800 $15,000
Q2 2019 Jul 30, 2019	SELL	$12.3 - $35.76 $2,460 - $7,152	-200 Reduced 6.9%	2,699 $34,000
Q1 2018 May 03, 2018	SELL	$59.7 - $99.25 $23,880 - $39,700	-400 Reduced 12.12%	2,899 $197,000
Q4 2017 Jan 31, 2018	BUY	$93.85 - $132.45 $69,449 - $98,012	740 Added 28.92%	3,299 $326,000
Q3 2017 Nov 08, 2017	BUY	$72.0 - $119.75 $184,248 - $306,440	2,559	2,559 $306,000

Others Institutions Holding PBYI

# of Institutions

110

Shares Held

28.3M

Call Options Held

27.9K

Put Options Held

3.4K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$12.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$12.5 Million
0.0% of portfolio
Acorn Capital Advisors, LLC New York, NY

2.45M
Shares

$8.6 Million
6.49% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$6.92 Million
0.02% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.89M
Shares

$6.65 Million
0.0% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $160M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account